Medicine Distribution Consents




NEW ZEALAND GAZETTE, No. 156
25 NOVEMBER 2010

Product:
Ondanaccord
Active Ingredient:
Ondansetron hydrochloride dihydrate 2mg/mL equivalent to 2mg ondansetron
Dosage Form:
Solution for injection
New Zealand Sponsor:
Accord Healthcare NZ Limited
Manufacturer:
Intas Pharmaceuticals Limited, Ahmedabad, India

Product:
Predictor
Active Ingredients:
Goat anti-(rabbit IgG) polyclonal antibody 2μg
Murine anti-beta-hCG monoclonal antibody-colloidal gold conjugate 2μg
Murine monoclonal antibody to alpha HCG 2μg
Normal Rabbit IgG-Colloidal Gold Conjugate 0.25μg
Dosage Form:
Pregnancy test kit
New Zealand Sponsor:
Arrow Pharmaceuticals (NZ) Limited
Manufacturer:
Tianjin New Bay Bioresearch Co. Limited, Tianjin, China

Product:
Solox Relief
Active Ingredient:
Lansoprazole 15mg
Dosage Form:
Capsule
New Zealand Sponsor:
Douglas Pharmaceuticals Limited
Manufacturer:
Liconsa SA, Guadalajara, Spain

Dated this 18th day of November 2010.

STEWART JESSAMINE, Acting Deputy Director-General, Population Health Directorate, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).

go8966

Renewal of Provisional Consent to the Distribution of a Medicine

Pursuant to section 23(4A) of the Medicines Act 1981, the Minister of Health hereby renews the provisional consent to the sale, supply or use in New Zealand of the medicine set out in the Schedule hereto:

Schedule

Product:
Proleukin
Active Ingredient:
Aldesleukin 18MIU
Dosage Form:
Powder for injection
New Zealand Sponsor:
Novartis New Zealand Limited
Manufacturers:
Novartis Pharmaceuticals UK Limited, West Sussex, United Kingdom
Bayer Health Care Pharmaceuticals Inc, Emeryville, United States of America

Note: This renewed consent is valid for two years from 27 January 2011.

Dated this 18th day of November 2010.

STEWART JESSAMINE, Acting Deputy Director-General, Population Health Directorate, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).

go8969

Consent to the Distribution of a New Related Product

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new related product set out in the Schedule hereto:

Schedule

Product:
Neutrogena Oil-Free Acne Wash Pink Grapefruit Facial Cleanser
Active Ingredient:
Salicylic acid 2%w/w
Dosage Form:
Skin wash
New Zealand Sponsor:
Johnson & Johnson (New Zealand) Limited
Manufacturer:
Vee Pak, Hodgkins, United States of America

Dated this 18th day of November 2010.

STEWART JESSAMINE, Acting Deputy Director-General, Population Health Directorate, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).

go8967

Provisional Consent to the Distribution of New Medicines

Pursuant to section 23(1) of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product:
Thalomid
Active Ingredient:
Thalidomide 50mg
Dosage Form:
Capsule



Next Page →



Online Sources for this page:

Gazette.govt.nz PDF NZ Gazette 2010, No 156





✨ LLM interpretation of page content

🏥 Consent to Distribution of New Medicines (continued from previous page)

🏥 Health & Social Welfare
18 November 2010
Medicines, Distribution, Ondanaccord, Predictor, Solox Relief
  • STEWART JESSAMINE, Acting Deputy Director-General, Population Health Directorate, Ministry of Health

🏥 Renewal of Provisional Consent to Distribution of Medicine

🏥 Health & Social Welfare
18 November 2010
Medicines, Renewal, Proleukin
  • STEWART JESSAMINE, Acting Deputy Director-General, Population Health Directorate, Ministry of Health

🏥 Consent to Distribution of New Related Product

🏥 Health & Social Welfare
18 November 2010
Medicines, New Related Product, Neutrogena Oil-Free Acne Wash Pink Grapefruit Facial Cleanser
  • STEWART JESSAMINE, Acting Deputy Director-General, Population Health Directorate, Ministry of Health

🏥 Provisional Consent to Distribution of New Medicines

🏥 Health & Social Welfare
18 November 2010
Medicines, Provisional Consent, Thalomid
  • STEWART JESSAMINE, Acting Deputy Director-General, Population Health Directorate, Ministry of Health